Melior Is Recognized as CRO of the Year by Life Sciences Review Life Sciences Review annually selects 10 preeminent CROs and has chosen Melior Discovery as the top CRO in 2023 The editors recognized Melior’s unique capabilities in the pre-clinical in vivo pharmacology space with its theraTRACE offering, its breadth…
Read More
Melior Discovery Announces Partnership with SFA on Grant Directed to Covid-19 - SFA Therapeutics receives award from Ben Franklin Technology Partners - - Melior Discovery selected as partner - See more here
Read More
Melior Discovery Announces Spinout of Melior Pharmaceuticals II, LLC See more here
Read More
Melior Discovery Receives Patent Approval from U.S. Patent and Trademark Office for New Parkinson’s Disease Drug Candidate Read more here
Read More
Melior Discovery Awarded SBIR Grant for Studying MLR-1023 Mechanism of Action Read more here
Read More
The Future of Drug Discovery: Two Required Supplements to Current Practices Read more here
Read More
Melior Discovery Enters New Pharmaceutical Collaboration Read more here
Read More